Top Rheumatoid Arthritis News
Keep up to date on all the latest Rheumatoid Arthritis research, drugs, and treatment.
-
FDA Warns of Percocet, Opioid Drug Mix-Up
The FDA has issued a warning that tablets, pills, and caplets of Percocet and eight other opioid products may have been mixed up and wrongly packaged as another. Read Summary > -
Excederin, Bufferin, Gas-X Recalled Over Mislabeled Pills
The company says that Excedrin and NoDoz bottles with expiration dates of Dec. 20, 2013, or earlier will be subject to recall. Read Summary > -
Exercise Eases Arthritis Pain in Overweight Mice
Scientists at Duke University Medical Center have found that obese mice on a high-fat diet demonstrated improvement in their osteoarthritis (OA) symptoms when they exercised. Read Summary > -
Some Rheumatoid Arthritis Drugs May Boost Skin Cancer Risk
A review of previous studies has found a link between the use of TNF inhibitors and an increased risk of skin cancer. Read Summary > -
New Rheumatoid Arthritis Drug Shows Promise
A new rheumatoid arthritis (RA) medication called sarilumab has shown positive results in a recent clinical trial. Read Summary > -
Some Rheumatoid Arthritis Drugs May Cut Diabetes Risk
According to a new study, two types of disease-modifying antirheumatic drugs used by many patients with rheumatoid arthritis and psoriasis may help reduce these patients' risk of developing diabetes. Read Summary > -
Drugmaker Issues Painkiller Recall Due to Labeling Error
The recall affects butalbital, acetaminophen, and caffeine tablets USP, 50mg/325mg/40mg, and hydrocodone bitartrate and acetaminophen tablets, USP 7.5mg/500mg. Read Summary > -
Depression Makes Arthritis Pain Worse: Study
South Korean scientists have found people who suffer from depression also experience more pain from knee osteoarthritis. Read Summary >
